Skip to main content

FDA Approves Pfizer’s Vaccine for Meningococcal Disease

The U.S. Food and Drug Administration has approved Pfizer’s application for Penbraya, a vaccine for people 10 through 25 that will offer protection against the five main kinds of bacteria that cause meningitis and blood poisoning.
The new drug will reduce the number of doses that people need to be fully vaccinated, Pfizer said in a news release. Penbraya will be given as a two-dose series administered six months apart, Pfizer said. Medical authorities currently recommend Trumenba for meningococcal group B and Nimenrix for meningococcal groups A, C, W-135, and Y, meaning people need four doses for full protection. “In a single vaccine, PENBRAYA has the potential to protect more adolescents and young adults from this severe and unpredictable disease by providing the broadest meningococcal coverage in the fewest shots,” Annaliesa Anderson, PhD, senior vice president and head of vaccine research and development for Pfizer, said in the release. Penbraya combines Trumenba, which is made by Pfizer, with Menveo, which is made by GSK and is similar to Nimenrix. The FDA based its decision on phase 2 and 3 clinical trials that showed Penbraya was “well-tolerated with a favorable safety profile,” Pfizer said. The FDA published its approval letter on Friday. Pfizer said the CDC’s Advisory Committee on Immunization Practices will meet Oct. 25 to discuss recommendations for the use of Penbraya in adolescents and young adults. Meningococcal meningitis is a rare but serious bacterial infection that infects the lining of the brain and the spinal cord. The CDC says children younger than 1, teens and young adults 16-23, and adults over 65 are most at risk.
Labels:

Comments

Post a Comment

Popular posts from this blog

Cervical Cancer: The Hidden Epidemic For Women In India

Cervical cancer, once a major health concern for women worldwide, is now experiencing a significant decline in its prevalence and impact. Thanks to advancements in medical research, increased awareness, and the implementation of effective preventive measures, the battle against cervical cancer is making remarkable progress. This article explores the current state of the fight against cervical cancer, highlighting the reasons behind its declining ranks as one of the leading cancers affecting women. Understanding Cervical Cancer Cervical cancer develops in the cells of the cervix, the lower part of the uterus that connects to the vagina. It is primarily caused by certain types of human papillomavirus (HPV), a sexually transmitted infection. The virus can lead to abnormal cell growth in the cervix, which, if left undetected or untreated, can progress to cervical cancer over time. Historically, cervical cancer has been a significant health concern, with high incidence rates and mortality
Post a Comment
Read more

Beauty-Natural Beauty Tips For Glowing Skin

Indigenous medicine, rooted in traditional knowledge and practices passed down through generations, offers a treasure trove of natural beauty remedies. From ancient healing traditions to holistic approaches, these beauty tips worldwide provide valuable insights into harnessing nature's bounty for radiant skin and overall well-being. There are several fascinating beauty secrets from different cultures, highlighting the wisdom of indigenous medicine. Turmeric-The Golden Spice for Radiant Skin from India: Turmeric, often called the "Golden Spice of India," is integral to Ayurvedic medicine and skincare. Known for its anti-inflammatory, antioxidant, and antimicrobial properties, turmeric can work wonders for the skin. Create a simple face mask by mixing turmeric powder with yoghurt or honey to reduce blemishes, brighten the complexion, and promote a youthful glow. Regularly using turmeric-based skincare products or incorporating it into your diet can also provide long-term
Post a Comment
Read more

What Is Multifocal Pneumonia?

Pneumonia, to put it most simply, is an infection of the lungs brought on by inflammation of the air sacs, or technically, alveoli. Coughing, fever, and chills are among the symptoms of those alveoli filling with fluid or pus. A lung infection known as multifocal pneumonia develops in multiple locations inside one or both lungs. Viruses commonly cause it, though bacteria, fungi, and viruses can also cause it. Furthermore, multifocal pneumonia typically has more muscular symptoms than other types of pneumonia. Diagnosis Of Multifocal Pneumonia The lobes that make up your lungs are like little balloons filled with tissue that resembles sponges. There are three lobes in the right lung and two in the left lung. The extent of lung involvement further limits the diagnosis of multifocal pneumonia. Multifocal pneumonia is a word used to describe pneumonia in multiple lung lobes. Two segments in the same lobe or two in separate lobes can be multifocal. Dr. C. Ugandhar Bhattu, Consultant Interv
Post a Comment
Read more